487 related articles for article (PubMed ID: 25583090)
1. Neutrophil gelatinase-associated lipocalin (NGAL) in heart transplant recipients after conversion to everolimus therapy.
Stypmann J; Fobker M; Rosing K; Engelen M; Gunia S; Dell'Aquila AM; Nofer JR
J Cardiol; 2015 Oct; 66(4):347-52. PubMed ID: 25583090
[TBL] [Abstract][Full Text] [Related]
2. Influence of conversion from calcineurin inhibitors to everolimus on fibrosis, inflammation, tubular damage and vascular function in renal transplant patients.
Alpay N; Ozkok A; Caliskan Y; Akagun T; Cinar SA; Deniz G; Sariyar M; Yildiz A
Clin Exp Nephrol; 2014 Dec; 18(6):961-7. PubMed ID: 24515306
[TBL] [Abstract][Full Text] [Related]
3. Plasma NGAL and glomerular filtration rate in cardiac transplant recipients treated with standard or reduced calcineurin inhibitor levels.
Gustafsson F; Gude E; Sigurdardottir V; Aukrust P; Solbu D; Goetze JP; Gullestad L
Biomark Med; 2014; 8(2):239-45. PubMed ID: 24521021
[TBL] [Abstract][Full Text] [Related]
4. Plasma neutrophil gelatinase-associated lipocalin and worsening renal function during everolimus therapy after heart transplantation.
Imamura T; Kinugawa K; Doi K; Hatano M; Fujino T; Kinoshita O; Nawata K; Noiri E; Kyo S; Ono M
Int Heart J; 2015; 56(1):73-9. PubMed ID: 25742944
[TBL] [Abstract][Full Text] [Related]
5. Plasma neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine, and glomerular filtration rate in patients after heart and lung transplantation.
Szewczyk M; Wielkoszyński T; Zakliczyński M; Zembala M
Transplant Proc; 2009 Oct; 41(8):3242-3. PubMed ID: 19857721
[TBL] [Abstract][Full Text] [Related]
6. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in heart allograft recipients.
Przybylowski P; Malyszko J; Malyszko JS
Transplant Proc; 2010 Jun; 42(5):1797-802. PubMed ID: 20620526
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 23 and Klotho as cardiovascular risk factors in heart transplant recipients.
Przybylowski P; Wasilewski G; Janik L; Kozlowska S; Nowak E; Malyszko J
Transplant Proc; 2014 Oct; 46(8):2848-51. PubMed ID: 25380933
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients.
Malyszko J; Malyszko JS; Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
Transplant Proc; 2009; 41(1):158-61. PubMed ID: 19249502
[TBL] [Abstract][Full Text] [Related]
9. Can HbA1c and cholesterol levels affect the neutrophil gelatinase-associated lipocalin (NGAL) after heart transplantation.
Dolapoglu A; Beketaev I
J Cardiol; 2015 Sep; 66(3):269. PubMed ID: 25881727
[No Abstract] [Full Text] [Related]
10. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study.
Lebkowska U; Malyszko J; Lebkowska A; Koc-Zorawska E; Lebkowski W; Malyszko JS; Kowalewski R; Gacko M
Transplant Proc; 2009; 41(1):154-7. PubMed ID: 19249501
[TBL] [Abstract][Full Text] [Related]
11. Serum Neutrophil Gelatinase-Associated Lipocalin and Cystatin C for Assessing Recovery of Graft Function in Patients Undergoing Living-Donor Kidney Transplantation.
Liu Y; Li HX; Ying ZW; Guo JJ; Cao CY; Jia W; Yang HR
Clin Lab; 2016; 62(1-2):155-63. PubMed ID: 27012045
[TBL] [Abstract][Full Text] [Related]
12. Kidney function assessed by eGFR, cystatin C and NGAL (neutrophil gelatinase-associated lipocalin) in relation to age in heart allograft recipients.
Przybylowski P; Malyszko J; Malyszko J
Med Sci Monit; 2010 Sep; 16(9):CR440-4. PubMed ID: 20802417
[TBL] [Abstract][Full Text] [Related]
13. Comparative assessment of neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C as early biomarkers for early detection of renal failure in patients with hypertension.
Gharishvandi F; Kazerouni F; Ghanei E; Rahimipour A; Nasiri M
Iran Biomed J; 2015; 19(2):76-81. PubMed ID: 25864811
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
[TBL] [Abstract][Full Text] [Related]
15. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
[TBL] [Abstract][Full Text] [Related]
16. Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients.
Rosing K; Fobker M; Kannenberg F; Gunia S; Dell'Aquila AM; Kwiecien R; Stypmann J; Nofer JR
Atherosclerosis; 2013 Sep; 230(1):164-70. PubMed ID: 23958269
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement.
Pronschinske KB; Qiu S; Wu C; Kato TS; Khawaja T; Takayama H; Naka Y; Templeton DL; George I; Farr MA; Mancini DM; Schulze PC
J Heart Lung Transplant; 2014 Dec; 33(12):1215-22. PubMed ID: 25049066
[TBL] [Abstract][Full Text] [Related]
18. Urinary neutrophil gelatinase-associated lipocalin accurately detects acute allograft rejection among other causes of acute kidney injury in renal allograft recipients.
Heyne N; Kemmner S; Schneider C; Nadalin S; Königsrainer A; Häring HU
Transplantation; 2012 Jun; 93(12):1252-7. PubMed ID: 22513480
[TBL] [Abstract][Full Text] [Related]
19. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients.
Malyszko J; Malyszko JS; Mysliwiec M
Clin Transplant; 2009; 23(5):681-6. PubMed ID: 19708926
[TBL] [Abstract][Full Text] [Related]
20. Is neutrophil gelatinase-associated lipocalin an optimal marker of renal function and injury in liver transplant recipients?
Hryniewiecka E; Gala K; Krawczyk M; Pączek L
Transplant Proc; 2014 Oct; 46(8):2782-5. PubMed ID: 25380917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
